Delivery Order 75N92023D00005-75N92023F00001
Award Date
7/1/23
Potential Completion Date
6/30/34
Potential Value
$7.7M
Federal Agency
National Heart Lung and Blood Institute
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Birmingham, AL 35294, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The University of Alabama at Birmingham (UAB) was awarded a federal contract by the National Heart, Lung, and Blood Institute (NHLBI) for $7,967,653.41 to support the Coronary Artery Risk Development in Young Adults (CARDIA) study. The contract, which runs from July 2018 to June 2023, does not have a set-aside designation. As the prime contractor, UAB is responsible for various tasks including blood sample tracking and inventory, DNA extraction and distribution, data security, and freezer...
This is a $1,050,298.53 federal contract award to the University of Alabama at Birmingham (UAB) by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The contract is for Task Area B under the Coronary Artery Risk Development in Young Adults (CARDIA) program, with a period of performance from November 14, 2019, to October 31, 2021, and an ultimate completion date of January 31, 2023. UAB is the prime contractor for this cost-no-fee...
This federal contract award to the University of Alabama at Birmingham (UAB) is for the Coronary Artery Risk Development in Young Adults (CARDIA) Study Coordinating Center. The National Heart, Lung, and Blood Institute awarded this $10,195,967.56 definitive, cost-no-fee contract to UAB, with a period of performance through June 30, 2018. The CARDIA study is a long-running longitudinal research effort focused on investigating cardiovascular disease development and risk factors in early adulthood....
This is a federal contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to the University of Alabama at Birmingham (UAB) on July 1, 2013. The contract, valued at $3,779,804.17, is for the CORONERY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) FIELD CENTER program. The contract has an ultimate completion date of June 30, 2018 and is a Definitive Contract with a Cost No Fee pricing type. The contract does not have a set-aside designation. UAB, a public research...
This is a federal contract award from the National Heart, Lung and Blood Institute (NHLBI) to the University of Alabama at Birmingham (UAB) for the Coronary Artery Risk Development in Young Adults (CARDIA) Study Coordinating Center. The $21,508,390.00 contract has an ultimate completion date of June 30, 2033 and is not set aside. The CARDIA study aims to assess the evolution of coronary artery disease risk factors in healthy young adults. UAB is the prime contractor, and key subcontractors...
This federal contract award with ID 75N92018D00007|75N92018F00001 was issued by the National Heart Lung and Blood Institute, a civilian agency, to the University of Alabama at Birmingham (UAB) as the prime contractor. The award is for the "CARDIA BIRMINGHAM FC - TASK AREA A" project with a period of performance from July 1, 2018 to June 30, 2019, and a ceiling value of $2,288,842.69. The contract is a delivery order with a cost no fee pricing type and is not set-aside. The CARDIA...
This is a delivery order issued under the Coronary Artery Risk Development in Young Adults (CARDIA) study contract, which is administered by the National Heart, Lung, and Blood Institute (NHLBI). The University of Alabama at Birmingham (UAB) is the prime contractor, with several subcontractors including the University of Massachusetts Medical School, Solomon Park Research Laboratories, the Medical University of South Carolina, and the University of Minnesota. The total ceiling value of this...
The University of Alabama at Birmingham (UAB) was awarded a $42,411,498.54 Definitive Contract by the National Institute of Allergy and Infectious Diseases (NIAID) Division of Extramural Activities (DEA) for biomedical research and services. This is a Cost No Fee contract with an ultimate completion date of December 1, 2013. UAB has a strong track record of securing federal funding for biomedical research, including grants from the National Institutes of Health (NIH). The contract does not...
This is a definitive federal contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to the University of Alabama at Birmingham (UAB), a non-profit educational institution. The contract, valued at $1,687,776.46, is for other ADP and telecommunications services. The contract does not have a set-aside designation. UAB has a strong track record of securing federal contracts and grants, including work for the Department of Defense, NASA, and the...
This is a definitive contract awarded by the U.S. government to the University of Alabama at Birmingham (UAB), a non-profit educational institution, on December 15, 2002. The contract has a firm fixed price of $1,497,441.00 and a completion date of June 30, 2007. There is no set-aside designation for this contract. UAB has an extensive track record of delivering biomedical and public health research under federal grant awards from agencies like the National Institutes of Health (NIH), Centers...